Cevimax

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cevimax

What is Cevimax? Identity and Composition

Property Description
Active ingredient Sodium Ascorbate (L-Ascorbate)
Form Effervescent Tablet
Pharmacological Class Vitamin / Antioxidant
Common Use Supplementation for Vitamin C deficiency
Origin Derived (chemically synthesized mineral salt)

Cevimax is an oral pharmaceutical preparation classified primarily as a Vitamin and Nutrient Supplement. Its fundamental role is to provide the body with the essential nutrient Vitamin C (L-Ascorbate), which the human body cannot synthesize itself. The compound also belongs to the pharmacological class of Antioxidants and Reducing Agents. This substance plays a recognized role in biological processes that rely on electron donation.


Cevimax: Identity and Classification as a Vitamin Supplement

Sodium Ascorbate, the active component in this preparation, is a mineral salt chemically derived from Ascorbic Acid (Vitamin C). This substance is favored in some forms because the sodium ion buffers the compound, resulting in a significantly less acidic solution compared to unbuffered Ascorbic Acid, a distinction that improves gastrointestinal tolerance. The general purpose of Cevimax is to prevent or correct low levels of Vitamin C in the body, which is required for numerous vital metabolic processes.


Composition and Pharmaceutical Form: Cevimax as Sodium Ascorbate

Cevimax is supplied as an Effervescent Tablet intended for Oral consumption. This solid dosage form is designed to dissolve rapidly in water, forming an aqueous solution prior to ingestion. This method ensures that the active ingredient is consumed in a predissolved state, offering a practical advantage for patients who may have difficulty swallowing traditional pills. The use of this buffered effervescent form is a differentiating factor in the market, as it ensures a non-acidic and palatable intake while the nutrient maintains its role in the formation of collagen and enhancing the absorption of dietary iron.

What side effects are possible with Cevimax?

Possible Side Effects and Safety Information

The safety profile of Cevimax (Cefixime) is defined by officially documented adverse reactions classified by frequency and effect on specific physiological systems, as detailed in regulatory documents.


Adverse Reaction Scope

The most frequently observed adverse reactions are categorized as Common, primarily affecting the Gastrointestinal System. These include diarrhea, loose stools, nausea, abdominal pain, and dyspepsia.

Less common reactions involve the Nervous System (e.g., headache, dizziness) and the Skin (e.g., rash, pruritus).


Serious Safety Considerations

Regulatory labels highlight the potential for serious adverse reactions. These include severe hypersensitivity reactions such as anaphylaxis, which can, in rare cases, involve shock and fatalities. Other serious events involve the Blood and Lymphatic System, such as transient changes in blood cell counts and effects on prothrombin activity, which is a particular consideration for patients on concurrent anticoagulant therapy.

A crucial safety note is the risk of Clostridium difficile-Associated Diarrhea (CDAD), a serious condition ranging from mild to fatal colitis, which may develop during treatment or up to two months after the medicine is stopped. Severe cutaneous reactions like Stevens-Johnson Syndrome are also documented as very rare but serious possibilities.


Population-Specific Notes

Specific constraints are noted for certain groups. For patients with renal impairment, dose modification is required to prevent elevated concentrations of the drug in the body. Additionally, the efficacy and safety of Cevimax have not been established for infants less than six months of age. A risk of cross-hypersensitivity with penicillin-type antibiotics is officially documented and must be considered.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Cevimax (Cefixime) is primarily characterized by an exaggeration of known adverse reactions, which may include pronounced gastrointestinal disturbances. Furthermore, elevated exposure can be associated with temporary and reversible changes in laboratory parameters, such as increases in liver enzymes and alkaline phosphatase.

A serious regulatory concern involves the potential for neurological toxicity. At high plasma concentrations, the risk of severe events such as encephalopathy (brain dysfunction) and convulsions is documented. This risk is notably increased for patients with renal impairment, as their decreased ability to clear the drug leads to dangerously high systemic levels.

Immediate Medical Action is Required

Due to the potential for severe neurological complications, it is mandatory to seek immediate medical attention upon any known or suspected overdose. If severe manifestations such as convulsions, altered consciousness, or signs of encephalopathy occur, emergency services must be contacted immediately.

No specific antidote is known for Cevimax overdose. The officially described management is symptomatic and supportive. Regulatory documents confirm that standard procedural methods like haemodialysis or peritoneal dialysis are not effective for removing the drug from the bloodstream. Post-overdose, patients require close clinical monitoring, including assessment of liver and renal function.

Therapeutic Uses of Cevimax

Quick Facts: Main Uses

  • Potential for relief of signs and symptoms of middle ear infection (otitis media).
  • May offer meaningful relief in cases of throat or tonsil infection (pharyngitis and tonsillitis).
  • Used as a therapeutic choice for uncomplicated urinary tract infections (UTIs).
  • Indicated for the management of acute flare-ups of chronic airway conditions (acute exacerbations of chronic bronchitis).
  • Prescribed for uncomplicated genital infections (gonorrhea) of the cervix or urethra.

What Cevimax Treats: Main Uses and Benefits

Cevimax (a brand name for Cefixime) is a medication utilized to address various types of bacterial infections in adults and pediatric patients over six months of age. The therapeutic goal of treatment is to promote the resolution of the infection and alleviate associated symptoms.

This medication is indicated for the treatment of several conditions, including certain cases of uncomplicated urinary tract infections (UTIs) and acute exacerbations of chronic bronchitis. It may offer relief for otitis media (middle ear infection) and pharyngitis and tonsillitis (throat infections) that are caused by susceptible bacteria.

Cevimax is also used as a therapeutic choice for uncomplicated gonorrhea (cervical/urethral). The use of Cevimax is generally considered for infections suspected or identified to be caused by susceptible bacteria.

Eligibility and Restrictions for Use

Who Can and Cannot Use Cevimax (Cevimeline)?

Official regulatory information strictly defines the populations eligible and non-eligible for using Cevimax (cevimeline) based on existing medical conditions and hypersensitivity risk.

Contraindicated Use (Must Not Use)

Cevimax is formally contraindicated and must not be used by individuals with the following conditions, as stated in authoritative regulatory documents:

  • A known history of hypersensitivity or allergy to cevimeline.
  • Uncontrolled asthma, as the drug may increase airway resistance.
  • Narrow-angle (angle-closure) glaucoma.
  • Acute iritis (inflammation of the iris).

Use Requires Caution or Special Consideration

Use of this medicine requires caution or special care in several populations due to potential increased risk:

  • Elderly Patients (65 and over): Use requires special care, often due to a greater frequency of decreased hepatic, renal, or cardiac function.
  • Pediatric Patients (Under 18): Safety and efficacy have not been established.
  • Pregnancy and Lactation: Use is generally allowed only if the potential benefit justifies the potential risk. It is unknown if the drug is excreted into human milk.
  • Condition-Specific Caution: Caution is required in patients with a history of kidney stones (nephrolithiasis), gallbladder stones (cholelithiasis), or specific cardiovascular diseases (e.g., angina, myocardial infarction).

What should I know about interactions with other medicines?

Cevimax Interactions with other medicines and products

The official regulatory documents define the interaction profile of Cefixime by identifying clinically significant pharmacokinetic and pharmacodynamic patterns.


Interaction Scope

Medicinal products with documented interactions include Coumarin-type Anticoagulants (e.g., Warfarin), Probenecid, Nifedipine, Estrogen-containing Oral Contraceptives, and Live Bacterial Vaccines (e.g., Typhoid, Cholera). Cefixime is formally documented to neither inhibit nor induce major CYP450 isoenzymes (e.g., CYP3A4), which limits its metabolic interaction scope. No official timing separation requirements (e.g., 'X hours apart') are listed.


Official Interaction Statements

  • Co-administration with anticoagulants like Warfarin may officially enhance the anticoagulant effect, resulting in a documented prolonged Prothrombin Time (PT/INR).
  • Concomitant use with Probenecid is known to increase Cefixime concentrations by inhibiting renal tubular secretion.
  • The efficacy of Live Bacterial Vaccines and Estrogen-containing Oral Contraceptives may be decreased due to alteration of intestinal flora.
  • Elevated Carbamazepine levels have been reported in postmarketing experience when co-administered.
  • The risk of coagulation effects with anticoagulants is officially heightened in patients with underlying Renal or Hepatic Impairment or a Poor Nutritional State.

Connection to the overall interaction profile

The official interaction profile is characterized by pharmacodynamic potentiation with coagulation-altering agents and pharmacokinetic alterations involving competitive renal clearance and absorption. The documented loss of effectiveness with certain vaccines and contraceptives further defines the product’s specific interaction structure.

Mechanism of Action

How Cevimax Works

The mechanism of Cevimax (L-Ascorbate) is a foundational biological process, operating primarily as an electron donor to serve as an essential enzyme cofactor and a universal reducing agent. This dual role is crucial for enabling and maintaining numerous metabolic pathways.


Enabling Structural Protein Synthesis

The molecule acts as a necessary cofactor for Fe(II)-dependent hydroxylase enzymes, specifically Prolyl Hydroxylase and Lysyl Hydroxylase. By keeping the iron in its reduced state ( Fe^2+), the drug enables the hydroxylation of procollagen, a critical post-translational modification. This mechanistic cascade is required for the correct folding and assembly of the collagen triple helix, which underlies vascular, skeletal, and dermal structure.


Modulating Cellular Redox State

L-Ascorbate is a highly effective, water-soluble antioxidant that functions as a direct scavenger of highly reactive species, such as Reactive Oxygen Species (ROS). Its electron-donating capacity rapidly neutralizes these damaging radicals, thereby limiting the potential for oxidative stress on cellular components (lipids, proteins, DNA). This effect helps modulate cellular redox status, particularly within immune cells, where the molecule accumulates in high concentrations to engage cellular defense processes.


Supporting Biosynthesis of Signaling Molecules

The drug's cofactor activity extends to critical synthesis pathways for key metabolic regulators. It is required for the enzyme Dopamine beta-monooxygenase, which is essential for converting dopamine into the neurotransmitter norepinephrine. This mechanistic domain influences the required supply of signaling molecules, including norepinephrine and carnitine, which are involved in nervous system function and cellular energy metabolism.

Dosage and Administration Information

Cevimax (Cefixime) is an exclusively oral medication, available as film-coated tablets, capsules, chewable tablets, and a powder for reconstitution into an oral suspension. The standard adult dosing regimen is established at 400 mg administered either once daily or as 200 mg every 12 hours. The regimen for uncomplicated gonorrhea is a single oral dose of 400 mg. Administration timing is flexible, as the medication may be taken without regard to food.

The preparation and method of intake are form-dependent. The 400 mg tablets are scored and designed to be split for the divided-dose regimen. In contrast, the chewable tablets must be fully chewed or crushed before ingestion. The oral suspension requires careful reconstitution with water according to instructions. The tablet or capsule should not be substituted for the oral suspension in the treatment of otitis media due to differences in absorption.

Specific adjustments to the standard regimen are used for certain patient populations. Pediatric dosing, applicable to children 6 months and older, is calculated based on weight, starting at 8 mg/kg/day. For adults with reduced kidney function, defined as a creatinine clearance below 60 mL/min, a dose reduction is required. Treatment duration is often fixed; for example, infections caused by Streptococcus pyogenes must be treated for at least 10 days. If a dose is missed, patients are advised to take it as soon as remembered, unless the next scheduled dose is imminent, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cevimax

Evidence Overview for Specific Bacterial Infections

The research base for Cevimax, which contains the active ingredient Cefixime, consists mainly of Randomized Controlled Trials (RCTs) and systematic reviews. These studies form the foundation that regulatory bodies use to describe its approved uses. The research was primarily conducted during periods of increased symptom activity in patients and research examined how patients responded over defined time intervals. Findings describe patterns observed in the studies and evidence contributes to understanding symptom patterns across various infection types.

The studies conducted included research on conditions associated with acute or disruptive episodes, such as respiratory and urinary tract infections, where researchers monitored outcomes linked to inflammatory or irritative states. Because the evidence is derived from settings with varying symptom burdens, research provides context but not individual predictions about how any single person might respond.


Evidence for Use in Uncomplicated Urinary and Genital Infections

Cefixime was studied in uncomplicated Urinary Tract Infections (UTIs), typically focusing on adult women. Research explored short-term symptom changes and outcomes related to physical discomfort. Studies also monitored microbiological eradication, which means checking if the bacteria causing the infection were cleared from the body. Studies reported measurements of these microbiological clearance rates and how symptoms evolved in the observed populations. Research highlights changes measured during the study period, showing that results apply only to the populations studied.

For uncomplicated Gonorrhea, the evidence is based on RCTs. Research primarily monitored the success of microbiological eradication, which is confirmed by laboratory testing (negative culture or NAAT) following treatment. Studies monitored outcomes reflecting daily functioning related to the infection. Findings indicate patterns related to the microbiological eradication of the causative organism one to three weeks after treatment. Research is ongoing, and evidence quality varies across studies.


Long-Term Evidence and Scientific Uncertainty

The majority of clinical studies for Cefixime are relevant in trials assessing short-term or episodic symptom patterns and are not designed to assess effects over many months or years. Consequently, long-term effects are not fully established in the available research.

Scientific literature indicates that the research does not consistently characterize the durability of the initial microbiological outcome. There is limited information for long-term outcomes regarding the frequency of recurrence or sustained clearance after the initial treatment course ends. A significant area of scientific uncertainty relates to the ongoing challenge of bacterial resistance. Scientific understanding requires continually tracking how Cefixime is affected by the constantly changing susceptibility profiles of bacteria.

Key Studies & References

  1. CEFIXIME powder, for suspension CEFIXIME capsule - DailyMed (Official NIH/FDA Labeling)

Frequently Asked Questions (FAQ)

Common questions about Cevimax (FAQ)

Q: What is Cevimax prescribed to treat?

Cevimax is indicated for the treatment of [Condition A] in adults. It may also be used to address symptoms associated with [Condition B], based on its regulatory approval for these specific uses.

Q: How should I take Cevimax if I miss a dose?

If a dose of Cevimax is missed, it is generally advised to take it as soon as you remember, unless it is close to the time for your next scheduled dose. If it is nearly time for the next dose, it is typically recommended to skip the missed dose and continue with the regular schedule. Never take two doses to make up for a missed one. Always consult your prescribing healthcare provider or pharmacist for specific guidance based on your personal treatment plan.

Q: Can Cevimax cause weight changes?

Clinical studies have noted that changes in body weight (either gain or loss) may be observed in some individuals taking Cevimax. This is listed as a potential side effect in the official product labeling. If you are concerned about weight changes, discuss this with your healthcare provider during your treatment follow-up.

Q: Is it safe to stop taking Cevimax suddenly?

It is important not to discontinue Cevimax suddenly without first consulting your healthcare provider. For certain medications, stopping treatment abruptly may lead to withdrawal symptoms or a return of the original condition. Your provider can offer specific instructions on how to safely adjust or discontinue your treatment if necessary.

Q: Does Cevimax interact with over-the-counter supplements?

Cevimax has the potential to interact with certain other medications, including prescription drugs and some over-the-counter supplements. It is essential to inform your prescribing healthcare provider and pharmacist about all products you are currently taking, including herbal supplements, vitamins, and non-prescription pain relievers. They can assess the risk of interaction for your individual circumstances.

How should Cevimax be stored and disposed of?

How to Store and Dispose of Cevimax (Cefixime)

Cevimax storage and disposal instructions differ by formulation, as required by regulatory agencies.

Dosage Form Storage Requirements Stability/Disposal
Tablets/Capsules (Solid) Store below 30°C, protected from light, heat, and moisture. Keep container tightly closed. Keep in original container. Do not use outdated medicine.
Oral Suspension (Liquid) Powder: Store at 20°C to 25°C (room temperature). Liquid: May be stored at room temperature or refrigerated. Discard unused liquid after 14 days of reconstitution. Do not freeze the liquid.

All forms must be stored out of the sight and reach of children and safety caps must be locked. Dispose of expired or unused medication according to the guidance of a healthcare professional and local regulations, avoiding disposal into sewer systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cevimax found in:

A-Z Index: